Overview
Lactate is an end product of anaerobic glycolysis and is formed when glucose is converted to energy in the absence of sufficient oxygen. It plays an important physiological role as an energy substrate, contributing significantly to cardiac oxidation and brain metabolism. In the brain, it provides a portion of energy requirements at rest and increases during physical activity. It is produced in the blood and can be oxidized by neurons or converted into glycogen. Measurement in plasma and cerebrospinal fluid serves as a valuable and cost-effective biomarker, particularly for evaluating systemic hypoxia and central nervous system pathology.
Symptoms
Elevated lactate levels are associated with symptoms of lactic acidosis, which may include shortness of breath, rapid breathing, sweating, nausea, muscle weakness, abdominal pain, paleness, and, in severe cases, coma. These symptoms reflect underlying tissue hypoxia, impaired oxygen utilization, or metabolic dysfunction rather than lactate elevation itself.
Causes
Under normal aerobic conditions, pyruvate enters the Krebs cycle for energy production. During anaerobic or hypoxic states, pyruvate is converted to lactate by the enzyme lactate dehydrogenase. Muscle cells and red blood cells are major sources of lactate production, although any tissue can contribute. Raised plasma lactate levels may occur in conditions such as diabetes mellitus, malignancy, alcoholism, toxic alcohol exposure, HIV infection, mitochondrial dysfunction, thiamine deficiency, and use of beta-adrenergic agonists. Elevated CSF lactate reflects altered metabolism within the central nervous system, often due to hypoxia, ischemia, or increased glycolysis.
Risk Factors
Risk factors for elevated plasma lactate include systemic hypoxia, sepsis, shock, critical illness, metabolic disorders, and impaired mitochondrial function. CSF lactate elevation is associated with bacterial meningitis, epilepsy, intracranial hemorrhage, cerebral ischemia, stroke, traumatic brain injury, and mitochondrial disorders affecting the CNS. Post-neurosurgical patients are at risk for elevated CSF lactate, which helps differentiate bacterial meningitis from aseptic inflammatory conditions.
Prevention
There are no direct preventive measures to avoid lactate elevation; prevention focuses on early detection and management of underlying causes. Its testing involves measurement of lactate levels in blood or, less commonly, cerebrospinal fluid. Proper sample collection is essential, including avoiding prolonged tourniquet use and fist clenching, as these can falsely elevate blood lactate levels.
Plasma lactate testing is useful for assessing systemic hypoxia, tissue perfusion, and severity of illness, while CSF lactate testing is particularly valuable in distinguishing bacterial meningitis from viral meningitis, as CSF lactate rises early in bacterial infections and remains normal in viral cases. Serial lactate monitoring and assessment of lactate clearance provide important prognostic information, with persistently elevated levels indicating worse outcomes and higher mortality risk.
